OOIR: Observatory of International Research

Papers

(The H4-Index of Neurobiology of Disease is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
The predictive value of mBDNF for major adverse cardiovascular events in stable coronary artery disease patients with depressive symptoms: A single-center, 5-year follow-up study	183
The neoliberal leaning of the neuroscience discourse when it deals with mental health and learning disorders	167
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition	128
Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network	121
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner	119
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments	105
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit	101
Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism	101
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain	95
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours	88
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers	85
Intermittent fasting produces antidepressant-like effects by modulating dopamine D1 receptors in the medial prefrontal cortex	82
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease	80
Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys	80
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice	77
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease	73
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy	72
Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis	70
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration	68
Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy	68
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs	67
Metabolic reprogramming of glial cells: Fatty acid pathways as regulators of remyelination in multiple sclerosis	65
Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics	63
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease	63
Inflammation in dementia with Lewy bodies	62

Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression	62
New perspectives on the role of biological factors in anorexia nervosa: Brain volume reduction or oxidative stress, which came first?	61
Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy	61
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model	61
A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes	60
Corrigendum to “Isoflurane on brain inflammation” [Neurobiology of Disease, 62 (2014) Pages 365–371]	58
Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease	58
Neuronal MeCP2 in the dentate gyrus regulates mossy fiber sprouting of mice with temporal lobe epilepsy	58
Hippocampal seizures differentially modulate locus coeruleus activity and result in consistent time-locked release of noradrenaline in rat hippocampus	58
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity	57
Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease	56
Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment	56
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease	54
Structural and functional abnormalities in thalamic neurons following neocortical focal status epilepticus	53
Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure	53
Corrigendum to “Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy” [Neurobiology	53
Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism	52
Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease	52
Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review	52
Cerebrospinal amino acid profiling in a large cohort of neuropediatric patients with epilepsy	52
miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy	52
B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis	51
Altered static and dynamic functional connectivity of the default mode network across epilepsy subtypes in children: A resting-state fMRI study	51
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models	50
Rhythms in barriers and fluids: Circadian clock regulation in the aging neurovascular unit	50